ASCEND BY NTHRYS
Research Abroad Products

Bacteriophage Genomics Project Topics

Browse all focused areas across all project categories under this field.

Showing 133–144 of 200 project topics
Phage Genomics Database and Strain Matching Software Tool
An enterprise software tool that catalogs thousands of sequenced bacteriophage genomes and matches them against pathogenic bacteria isolated from veterinary samples for optimal phage selection. Monetizes through licensing fees, API access, and premium strain identification services to pharmaceutical and biotech companies.
Bacteriophage Veterinary Application Development Click to view more details →
Aquaculture-Specific Phage Biofilm Degradation Treatment Service
A specialized service delivering customized phage formulations designed to disrupt bacterial biofilms in fish farming systems and reduce mortality from vibriosis and other tank-associated diseases. Monetizes through per-treatment service contracts and maintenance agreements with aquaculture facilities worldwide.
Bacteriophage Veterinary Application Development Click to view more details →
Phage-Based Microbial Quality Control Testing for Animal Feed
A rapid microbial testing platform using phage-based detection to identify Salmonella, E. coli, and other contaminants in animal feed before distribution to farms. Generates revenue through testing fees and partnerships with feed manufacturers, distributors, and quality assurance laboratories.
Bacteriophage Veterinary Application Development Click to view more details →
Personalized Phage Therapy Development Contract Research Service
A contract research organization offering custom phage isolation, characterization, and formulation development for veterinary pharmaceutical companies developing novel therapeutic products. Delivers revenue through project-based contracts, milestone payments, and royalty arrangements with client companies.
Bacteriophage Veterinary Application Development Click to view more details →
Swine Disease Mitigation Phage Product Portfolio Management
A comprehensive suite of characterized bacteriophage products targeting porcine pathogens including Streptococcus suis, Actinobacillus pleuropneumoniae, and pathogenic E. coli strains. Achieves revenue through direct sales to swine producers, veterinary distributors, and pharmaceutical companies seeking replacement therapies.
Bacteriophage Veterinary Application Development Click to view more details →
Phage Sensitivity Prediction Algorithm for Bacterial Strain Typing
An artificial intelligence-powered tool that predicts which bacteriophages will be most effective against specific pathogenic bacterial isolates from veterinary samples using genomic and phenotypic data. Generates SaaS licensing revenue and integration fees from diagnostic laboratories and clinical decision support system providers.
Bacteriophage Veterinary Application Development Click to view more details →
Regulatory Compliance and Scale-up Manufacturing Support Consulting
A specialized consulting service guiding veterinary phage therapy companies through regulatory pathways, GMP manufacturing scale-up, and quality assurance requirements across multiple jurisdictions. Monetizes through consulting retainers, milestone-based fees, and ongoing compliance management contracts.
Bacteriophage Veterinary Application Development Click to view more details →
Integrated Phage-Antibiotic Combination Therapy Development Platform
A research and development platform for formulating synergistic phage-antibiotic combinations that enhance bacterial killing while reducing overall antibiotic dosages in veterinary medicine. Generates revenue through technology licensing, co-development partnerships, and sales royalties from pharmaceutical companies commercializing combination products.
Bacteriophage Veterinary Application Development Click to view more details →
Phage Regulatory Compliance Management SaaS Platform
A cloud-based platform that automates FDA, EMA, and international regulatory submission workflows for bacteriophage therapeutics, including CMC data organization and dossier generation. This reduces time-to-IND by 40% and eliminates costly compliance consulting fees, enabling faster market entry and reduced regulatory burden costs.
Phage Regulatory & Compassionate Use Strategy Click to view more details →
Compassionate Use Protocol Accelerator and Patient Enrollment Tool
An integrated software suite that streamlines expanded access applications, patient eligibility screening, and real-time enrollment tracking for phage therapy programs outside standard trials. This generates recurring licensing revenue while positioning sponsors as patient-centric innovators and capturing valuable real-world evidence data.
Phage Regulatory & Compassionate Use Strategy Click to view more details →
Phage Genome Annotation for Regulatory Submission Intelligence
An AI-powered bioinformatics tool that automatically annotates bacteriophage genomes, identifies safety-critical sequences, and generates regulatory-compliant reports for submission dossiers. This accelerates the characterization phase, reduces manual annotation labor costs by 60%, and mitigates regulatory rejection risk.
Phage Regulatory & Compassionate Use Strategy Click to view more details →
Real-World Evidence Collection Platform for Phage Therapeutics
A HIPAA-compliant digital health platform capturing clinical outcomes, safety signals, and efficacy metrics from compassionate use and post-market phage therapy patients via mobile and EHR integration. This generates proprietary RWE datasets that support label expansions, value-based pricing negotiations, and premium licensing partnerships.
Phage Regulatory & Compassionate Use Strategy Click to view more details →